Chief Medical Officer

Mind Medicine’s LSD Dose Cuts Anxiety for 12 Weeks in Trial

MindMed to Participate in September Investor Conferences

Psychedelic Drugs Market Size to Surpass USD 10.11 Billion by 2032, Fueled by Breakthrough Therapies and Expanding Mental Health Applications – SNS Insider

Six psychedelic drug companies aiming to revolutionize mental health treatment

IT Business Partner - CSV

MindMed is a clinical stage biopharmaceutical company developing innovative treatments for brain health disorders. The IT Business Partner - CSV will define validation strategies for GxP-regulated computerized systems, ensuring compliance and quality through collaboration with QA and other stakeholders.

Sign up with Google

Sign in with Google